The organization and expression of the mdm2 gene

Genomics

Volumn 33, Issue 3, 1996, Pages 352-357

  Montes De Oca Luna, Roberto ^a   Tabor, Amy D ^a   Eberspaecher, Heidi ^a   Hulboy, Diana L ^a   Worth, Laura L ^a   Colman, Michael S ^b   Finlay, Cathy A ^b   Lozano, Guillermina ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANIMAL TISSUE; ARTICLE; DEVELOPMENT; EMBRYO; GENE EXPRESSION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ORGANIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MURINAE;

EID: 0001393117     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1996.0210     Document Type: Article

References (25)

1. Barak, Y., Gottlieb, E., Juven-Gershon, T., and Oren, M. (1994). Regulation of mdm2 expression by p53: Alternative promoters produce transcripts with nonidentical translation potential. Genes Dev. 8: 1739-1749.
2. Barak, Y., Juven, T., Haffner, R., and Oren, M. (1993). mdm2 expression is induced by wild type p53 activity. EMBO J. 12: 461-468.
3. Chen, J., Marechal, V., and Levine, A. J. (1993). Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13: 4107-4114.
4. Fakharzadeh, S. S., Trusko, S. P., and George, D. L. (1991). Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10: 1565-1569.
5. Finlay, C. A. (1993). The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13: 301-306.
6. Haines, D. S., Landers, J. E., Engle, L. J., and George, D. L. (1994). Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol. Cell. Biol. 14: 1171-1178.
7. Heighway, J., Mitchell, E. L. D., Jones, D., White, G. R. M., Santibáñez Koref, M. F. (1994). A transcribed polymorphism and sublocalisation of MDM2. Hum. Genet. 93: 611-612.
8. Jones, S. N., Roe, A. E., Donehower, L. A., and Bradley, A. (1995). Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208.
9. Kawasaki, E. S. (1990). Amplification of RNA. In "PCR Protocols: A Guide to Methods and Applications" (M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White, Eds.), pp. 21-27, Academic Press, San Diego, CA.
10. Ladanyi, M., Cha, C., Lewis, R., Jhanwar, S. C., Huvos, A. G., and Healey, J. H. (1993). MDM2 gene amplification in metastatic osteosarcoma. Cancer Res. 53: 16-18.
11. Marechal, V., Elenbaas, B., Piette, J., Nicolas, J.-C., and Levine, A. J. (1994). The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 14: 7414-7420.
12. Martin, K., Trouche, D., Hagemeier, C., Sorensen, T. S., La Thangue, N. B., and Kouzarides, T. (1995). Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375: 691-694.
13. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
14. Montes de Oca Luna, R., Wagner, D. S., and Lozano, G. (1995). Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206.
15. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., and Vogelstein, B. (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83.
16. Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., and Vogelstein, B. (1993). Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362: 857-860.
17. Quesnel, B., Preudhomme, C., Fournier, J., Fenaux, P., and Peyrat, J.-P. (1994). MDM2 gene amplification in human breast cancer. Eur. J. Cancer 30A: 982-984.
18. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E. E., and Collins, V. P. (1993). Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res. 53: 2736-2739.
19. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). "Molecular Cloning: A Laboratory Manual," Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Schmid, P., Lorenz, A., Hameister, H., and Montenarh, M. (1991). Expression of p53 during mouse embryogenesis. Development 113: 857-865.
21. Sheikh, M. S., Shao, Z.-M., Hussain, A., and Fontana, J. A. (1993). The p53 -binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res. 53: 3226-3228.
22. Vogelstein, B., and Kinzler, K. W. (1992). p53 function and dysfunction. Cell 70: 523-526.
23. Wu, X., Bayle, J. H., Olson, D., and Levine, A. J. (1993). The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7: 1126-1132.
24. Xiao, Z.-X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J., Sellers, W. R., and Livingston, D. M. (1995). Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375: 694-698.
25. Zhao, G-Q., Zhao, S., Zhou, X., Eberspaecher, H., Solursh, M., and de Crombrugghe, B. (1994). rDlx, a novel distal-less-like homeoprotein is expressed in developing cartilages and discrete neuronal tissues. Dev. Biol. 164: 37-51.